Navigation Links
GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing

The CRISPR-Cas9 system introduces double-strand DNA breaks at a specific locus in the genome by using a complex of the Cas9 nuclease with either a chimeric single guide RNA (sgRNA) or two short RNAs (a CRISPR RNA (crRNA) and a trans-activating RNA (tracrRNA)). The ability of any given guide RNA (sgRNA or crRNA) to create a break in the target DNA that causes functional protein disruption can vary based on the guide RNA (gRNA) sequence and position in the targeted gene. Likewise, the overall specificity of RNA-directed DNA cleavage events is not yet completely understood and can hamper its wider application.

Dharmacon, part of GE Healthcare, presents a new educational webinar, “Improve CRISPR-Cas9 experiments with rationally designed guide RNAs,” which will discuss a new algorithm to score gRNA sequences based on how likely they are to produce functional knockout of targeted genes. The speaker is Alex Amiet, Senior Product Manager for Dharmacon Gene Editing, GE Healthcare.

While gRNAs targeting one or a few genes can often be chosen ad hoc, performing high throughput genome-scale loss-of-function screens requires gRNAs that have consistently high functional knockout efficiencies. To understand the parameters affecting CRISPR-Cas9 gene editing efficiency, GE systematically evaluated over 1100 synthetic crRNAs in a reporter assay and identified characteristics important for functional gene disruption. Using this data, they developed an algorithm to score gRNA sequences based on how likely they are to produce functional knockout of targeted genes. The algorithm was tested by designing synthetic crRNAs to genes unrelated to the original assay and examined their ability to knock out gene function using additional phenotypic assays. Results demonstrate that high-scoring crRNAs have increased functionality. Further, GE developed an optimized alignment program to perform complete specificity analysis of crRNAs, including detection of gapped alignments. Recent work has demonstrated gene editing by crRNAs containing bulges of up to 4 nucleotides, but a number of existing design tools are unable to detect putative off-targets based on gapped alignments.

Attendees who join will learn about:

  •     The importance of a thorough and accurate guide RNA specificity alignment
  •     How rational design of guide RNAs can improve CRISPR functionality
  •     The impact of genome-wide, algorithm-designed guide RNAs on gene editing efficacy and time to results

A live question-and-answer session will follow the presentation.

Alex Amiet is a Global Senior Product Manager at Dharmacon, part of GE Healthcare. She is responsible for developing and expanding the Edit-R™ Genome Engineering portfolio, working closely with a renowned team of R&D scientists to bring to market innovative CRISPR-Cas9 tools and services. In her ten-year tenure at Dharmacon, she has built and led the development of the novel portfolio of microRNA research tools from the ground-up and managed nearly the entirety of the Dharmacon product lines, including custom RNA and siRNA synthesis, shRNA, gene expression and genome-scale RNAi screening services for drug development. Alex studied Molecular Biology at the University of Houston and has developed new Life Science technology platforms for Thermo Fisher Scientific, Sigma-Aldrich and Degussa GmbH for over 16 years.

The free webinar, hosted by LabRoots, will be presented on September 29, 2015, at 8 am PT.
For full details and free registration, click here.

About Dharmacon:
Leveraging expertise in bioinformatics, RNA biology, and synthesis chemistry, the company has developed a complete line of products for the RNAi researcher. Further breakthroughs arose in chemical modifications for siRNA specificity, and novel molecules for microRNA modulation. In 2014, Dharmacon became part of GE Healthcare Life Sciences. For more information visit

About LabRoots:
LabRoots is the leading professional networking website designed to connect all science verticals. Founded in March 2008, LabRoots’ vision was to connect the scientific world leveraging a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise. LabRoots is the owner and producer of BioConference Live – which has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at

Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit
2. How “Clinical Efficacy” Can Rein in Healthcare Costs
3. 9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA
4. Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI
5. Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare
6. WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey
7. Santa Rosa Consulting Recognized by Modern Healthcare as One of the Top 100 Best Places to Work and from KLAS Research with the Highest Rating for Go-Live Support
8. Heart Fit Clinic Featured in Options Magazine as Cutting Edge Private Healthcare Clinic in Calgary
9. EDU Healthcare Finishes Best Year
10. GeBBS Healthcare Solutions Recognized for Seventh Time by Inc. Magazine as One of the Nation's Fastest Growing Companies
11. 5% of Texans Account for 55% of Healthcare Costs, Study Finds
Post Your Comments:
(Date:3/19/2020)... ... ... “We wanted to solve the challenges of safely getting testing for COVID-19 ... “A reliable at home testing kit that can be processed quickly allows us to ... of their own home, while maintaining the health of the general public." , Members ...
(Date:3/16/2020)... ... March 16, 2020 , ... ... deliver testing for Coronavirus SARS-CoV-2 (the virus that causes COVID-19 disease) to NKR’s ... the world and serves approximately 100 transplant programs throughout the United States. NKR ...
(Date:3/15/2020)... ... , ... 4 out of 5 Americans (82%) across party lines say it ... other countries. , Peter Yeo, President of the Better World Campaign said, “This poll ... including the U.S., can battle a pandemic on its own.” , Two thirds of ...
(Date:3/15/2020)... , ... March 13, 2020 , ... ... , There are approximately 700,000 people with autism in the world, using a ... with autism have access to a life-changing intervention known as Applied Behavioral Analysis. ...
(Date:3/15/2020)... ... March 15, 2020 , ... The response to the ... Because of our unique role in children’s education, Global Teletherapy would like to ... U.S. school districts. We feel a responsibility to do what we can ...
Breaking Medicine News(10 mins):
(Date:3/16/2020)... ... March 16, 2020 , ... In response to the COVID-19 pandemic, ... also closing nationwide . As of March 15, public schools across at least twenty-nine ... working from home while their children are also present. To help working parents adjust ...
(Date:3/15/2020)... , ... March 13, 2020 , ... ... news, and the World Health Organization (WHO) recently declared the outbreak a global ... the virus, which was first detected in Wuhan, China in December 2019. The ...
(Date:3/13/2020)... ... 13, 2020 , ... With locations in Staten Island, NY and East Brunswick, ... to offer the Light-Adjustable Lens (LAL) by RxSight™ to cataract patients. , The Light ... following cataract surgery, and it is the first FDA-approved IOL of this nature. The ...
Breaking Medicine Technology: